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PSTATE-OF-THE-ART PAPER
Minimally-Invasive Valve Surgery
Jan D. Schmitto, MD, PHD, Suyog A. Mokashi, MD, Lawrence H. Cohn, MD
Boston, Massachusetts
Minimally-invasive approaches have become increasingly important in cardiac valve surgery. Smaller incisions
have become commonplace in many major centers. We reviewed the existing literature and present the current
state-of-the-art of minimally-invasive valve operations in this paper. (J Am Coll Cardiol 2010;56:455–62)
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Tinimally-invasive cardiac valve surgery represents a recent,
ignificant paradigm shift. Traditionalists were initially
esistant to such techniques, claiming smaller incisions lead
o poor exposure and inferior outcomes. The rapid devel-
pment and refinement of techniques over the past decade
ave led to the realization that a minimally-invasive ap-
roach enables complex valve surgery to be performed with
esults, at the very least, equivalent to those of conven-
ional (open) valve surgery done in experienced centers.
inimally-invasive valve surgery (mini-VS) has now
volved into a safe, efficient treatment option providing
reater patient satisfaction and fewer complications. All
ini-VS are undertaken only after becoming skilled in
erforming the conventional operations.
ethods
thorough literature search was performed using
EDLINE. Search strategy combined “mitral valve,” “aor-
ic valve,” and “minimally invasive.” The search was also
xtended to Cohn’s textbook Cardiac Surgery in the Adult (1)
nd various reviews (2–8).
istory
he first successful cardiac operation was performed on
eptember 7, 1896, in Frankfurt, Germany by Rehn (9),
ollowed by the first successful cardiac valve operation in
912 by Tuffier (10) and the first successful mitral valve
MV) operation in 1923 (11). In 1956, Lillehei repaired
ultiple valvular lesions through a right thoracotomy using
ardiopulmonary bypass (CPB) (12). The ensuing years
itnessed the rapid development of various valvular pros-
heses placed via a conventional approach—a full sternot-
my with CPB.
rom the Division of Cardiac Surgery, Brigham and Women’s Hospital, Harvard
edical School, Boston, Massachusetts.d
Manuscript received October 2, 2009; revised manuscript received March 5, 2010,
ccepted March 9, 2010.In the 1990s, the success of laparoscopic operations in
eneral surgery renewed an interest in minimally-invasive
pproaches for cardiac surgery. Navia and Cosgrove (13)
nd Cohn et al. (14) performed the first minimally-invasive
alve operations (via the right parasternal and transsternal
pproaches). Remarkably, excellent exposure was achieved
hrough smaller incisions, thereby making complex valve
epair possible and safe.
In 1996, Carpentier et al. (15) performed the first
ideo-assisted mitral valve repair (MVR) through a mini-
horacotomy using ventricular fibrillation. With more expe-
ience, video-assisted, 2-dimensional endoscopes and robot-
cs were introduced by Carpentier et al. (15) and Chitwood
t al. (16,17). Soon thereafter in 1998, the Leipzig group
Germany) used a 3-dimensional videoscope with voice-
ctivated robot assistance (Aesop 3000, Computer Motion,
oleta, California), enabling solo surgery (18). Also in that
ame year, Carpentier et al. (19) performed the first com-
letely robotic MVR using the Da Vinci Surgical System
Intuitive Surgical, Inc., Sunnyvale, California).
An important adjunct in the evolution of mini-valve
urgery (mini-VS) is the parallel progress in perfusion
echnology. First, smaller, nonkinking arterial and venous
annulae have been combined with vacuum-assisted venous
rainage to allow maximal space use provided by the smaller
ncisions. Second, the implantation of transjugular coronary
inus catheters provides cardiac protection via retrograde
ardioplegia. Third, the application of carbon dioxide
CO2) into the operating field limits intracardiac air (to
educe air embolism). Finally, intraoperative transesopha-
eal echocardiography allows for real-time monitoring of
ardiac distention, de-airing, and cannula placement (20).
Thus, mini-VS has evolved into a routinely performed
peration with excellent results in many specialized centers
13,21–24).
efinition of Mini-VS
he Society of Thoracic Surgeons (STS) database (25)
efines minimally-invasive cardiac surgery as “any procedure
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notomy and CPB support.” Ac-
cording to Chitwood et al. (26,27),
mini-VS should not be defined
in terms of a specific procedure,
but rather a “philosophy” that re-
quires an operation-specific strat-
egy. Each minimally-invasive
strategy introduces alternatives
for CPB cannulation (central or
peripheral), aortic occlusion (en-
dovascular or transthoracic), and
cardioplegia delivery (antegrade,
atrial retrograde, or transjugular
retro-retrograde). At the Brigham
and Women’s Hospital (BWH),
mini-VS does not involve a com-
plete sternotomy but instead uses
a partial sternotomy or limited
thoracotomy incision.
echniques of Mini-VS
ini-VS refers to a constellation of surgical techniques/
echnologies (Table 1) that minimize surgical trauma
hrough smaller incisions compared with a conventional
ternotomy. The most common minimally-invasive ap-
roach to the aortic valve (AV) is the upper partial sternot-
my, whereas with the MV, this includes a right mini-
horacotomy (28), a robotically assisted right thoracic
pproach (29), and a partial sternotomy (30).
By the mid-1990s, parasternal and transsternal ap-
roaches were being described by Navia and Cosgrove (13)
nd Cohn et al. (14). Smaller incisions lateral to the sternum
ere created, with or without resection of the third or fourth
ostal cartilage. However, their disadvantages included fem-
ral CPB cannulation, ligation of the right internal thoracic
rtery, occasional chest wall instability, and difficult conver-
ion to full sternotomy. In 1997, Cohn et al. (28) presented
4 minimally-invasive cases (41 aortic, 43 mitral) using a
ight parasternal incision and excising the third and fourth
ostal cartilage. Interestingly, greater patient satisfaction, a
ecrease in post-operative atrial fibrillation (AF), and over-
ll lower costs were found (28). Later, Greelish et al. (29)
rimarily used a lower mini-sternotomy for mini-MVS with
xcellent results.
Specially designed instruments facilitate mini-VS via a
horacotomy. Chitwood et al. (16) designed a new aortic
lamp that allows transthoracic aortic occlusion. Video
ssistance has also been used for mini-VS through small
horacotomies (17,21,22). Although there are highly en-
ouraging results using a right thoracotomy, several disad-
antages exist, including peripheral CPB cannulation, the
eed for a double-lumen endotracheal tube, and occasional
ifficulty with MV exposure (21). Another important tech-
ique is the port access for mini-MVS (30), with promising
Abbreviations
and Acronyms
AF  atrial fibrillation
AV  aortic valve
BWH  Brigham and
Women’s Hospital
CPB  cardiopulmonary
bypass
Mini-MVS  minimally-
invasive mitral valve
surgery
Mini-VS  minimally-
invasive valve surgery
MV  mitral valve
MVR  mitral valve repair
STS  Society of Thoracic
Surgeonsesults (31–34). However, the port access technique, mainlyerformed by the Stanford group, continues to be associated
ith some risk (peripheral CPB cannulation and a high rate
f retrograde aortic dissection caused by using the balloon
atheter to occlude the aorta and provide cardioplegia). An
-cm anterolateral thoracotomy via the third intercostal
pace, direct aortic clamping, and cannulation have been
escribed by Angouras and Michler (35).
Telemanipulators, robotics that allow a handlike mecha-
ism to be controlled by a human operator, were first used
n Paris, France by Carpentier et al. (15) and Falk et al. (18)
n Leipzig, Germany. Telemanipulator-supported opera-
ions, which involve femoral cannulation and direct or endo-
uminal aortic clamping, have been used and propagated by
hitwood et al. (17,23) and others (36,37), who claim that
his technique could be safely and effectively used (28).
ecently, another group reported the results of 25 patients
eceiving successful telemanipulator-supported mini-MVS
38); however, long-term results are not available. Other
enters (Leipzig) had similar positive experiences using the
elemanipulator-supported techniques in the late 1990s
39,40). However, they later abandoned this technique,
iven the lack of difference compared with their “standard”
pproaches. In 2009, Wang et al. (41), in Nanjing, China,
resented a new approach for MV replacement through a
ight vertical infra-axillary thoracotomy with excellent re-
ults (0.5% mortality).
esults
uring the past 15 years, cardiac surgeons worldwide have
eported their mini-VS data with promising results. The
arious Approaches/Incisionsf Minimally-Invasive Valve SurgeryTable 1 V riou Approaches/Incisionsof Minimally-Invasive Valve Surgery
Thoracotomy
Right anterior thoracotomy, second and third intercostal spaces (52,78)
Right anterior thoracotomy, fourth and fifth intercostal spaces (85)
Left lateral thoracotomy (40)
Left posterior thoracotomy (51)
Right vertical infra-axillary thoracotomy (41)
Partial sternotomy
Parasternal incision (6,13,14)
Transsternal incision (6)
Upper sternotomy (7)
T mini-sternotomy (86)
Inverted T sternotomy (87)
Reversed L-shaped partial upper sternotomy (88)
Reversed L incision (89)
Inverse L incision (86)
J incision (6,90)
V incision (91)
Video-assisted
Port access (30–34)
Robot-assisted
AESOP 3000 (Computer Motion, Goleta, California) (6,18)
Da Vinci (Intuitive Surgical, Inc., Sunnyvale, California) (19)Zeus (Computer Motion, Goleta, California) (6)
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August 3, 2010:455–62 Minimally-Invasive Cardiac Valve Surgeryain statement is that minimally-invasive operations can
rovide excellent, safe, and familiar exposure of the MVs
nd AVs with results comparable to those with conventional
pproaches. However, a randomized, prospective trial com-
aring minimally-invasive and conventional valve opera-
ions is still lacking. We therefore must rely on retrospective
mostly single-center) clinical evaluation trials.
ortality. After reviewing all comparative mini-VS stud-
es evaluating mortality, no study showed a significant
ifference between minimally-invasive and conventional
pproaches (42–49).
At our institution (BWH), the mortality rate is compa-
able to that with conventional valve approaches. In 1997,
ohn et al. (28) reported a low mortality rate in mini-VS:
of 41 patients (5%) for the AV replacement/repair and 0
f 43 patients (0%) for MV. Both operative deaths were in
ew York Heart Association functional class IV patients; 1
ied of liver failure and 1 died of an arrhythmia in a
eoperation (28). In 2001, Cohn et al. (8) presented 353
ini-MVS patients over a 5-year-period. The results
howed a mortality rate similar to that with conventional
ternotomy, a shorter intensive care unit/hospital stay, and
verall lower costs (8). Furthermore, this series found a
ower number of blood transfusions, incidence of AF, and
ost-discharge rehabilitation requirements; patients indi-
ated that they had a faster recovery (8). In 2003, Greelish
t al. (29) reported the first long-term results (5-year
ollow-up) of mini-VS, indicating a freedom from mitral
egurgitation and reoperation 90% of patients. In 2004,
ihaljevic et al. (3) from the BWH group showed that of
,042 patients undergoing AV surgery, 526 operations were
inimally invasive, with a mortality rate of 2% (12 of 526
atients), and in the mini-AV group, the mortality rate was
% (14 of 516) versus conventional sternotomy. Further-
ore, mini-MVS had an operative mortality rate of 0.2% (1
f 474) compared with 0.3% (1 of 337) with conventional
ternotomy. The freedom from reoperation rate at 6 years
as 95%, and the late mortality rate was 3% in the MV
roup (3).
In their early port access cases, Mohr et al. (34) reported
high mortality rate (9.8%) for mini-MVS, partially pro-
edure related, with 2 of 51 patients experiencing an aortic
issection (34). After discontinuing the port access tech-
ique, and modification and simplification of the surgical
rocedure, the mortality decreased to an in-hospital mor-
ality rate of 3.9% (4). The Leipzig long-term results
evealed an actuarial survival rate of 83% at 6.8 years (50).
hen excluding the initial 200 patients in whom an
ndoclamp was used, the overall results are even more
mpressive (50). In 2002, Mohr’s group (Onnasch et al.
45]) reported their 5-year experience performing mini-
VS in 449 patients, with a mean survival rate of 96.3% at
-year follow-up. In 2002, Grossi et al. (51) reported their
-year experience with mini-MVS in 714 patients, with
1.1% hospital mortality rate for isolated MVR and 5.8%
or isolated MV replacement. Morbidity included a perma- ment neurological deficit (2.9%) and aortic dissection
0.3%), respectively (51). They concluded that mini-MVS is
eproducible with low perioperative morbidity/mortality
nd late outcomes comparable to those with conventional
perations (51).
Casselman et al. (52) (Aalst, Belgium) reported their
esults with 306 patients undergoing mini-MVS in 2003.
heir MVR rate was 73.9%, and the overall hospital
ortality rate was 1%. In addition, post-operative morbid-
ties included re-exploration (8.5%), new-onset AF (17%),
nd pacemaker implantation (2.3%). Ninety-three percent
f patients stated that they would choose the same proce-
ure again, and 46.1% were back at work within 4 weeks.
hey concluded that endoscopic MVS can be performed
afely but definitely requires a learning curve (52). As a
esult, minimally-invasive approaches have become their
xclusive strategy for isolated atrioventricular valve dis-
ase (52).
Soltesz and Cohn (2) reported 890 mini-AVSs (875 AV
eplacement, 15 AV repair) that were performed at BWH
2) with a 30-day operative mortality rate of 2% (18 of 890)
ower than the risk-unadjusted mortality rate for AV re-
lacement from the STS database (3.4% to 4.4%). Of note,
57 of 890 were performed on patients 80 years or older
mean age 84 years) with an operative mortality rate of 1.9%
3 of 157), with no mortality among 34 octogenarians who
nderwent a minimally-invasive reoperative AV replace-
ent (2). Thus, this reveals exceptionally good survival for
his age, suggesting that the benefits of mini-VS may be
ncreased in higher-risk subgroups (2,3).
osmesis. Improved cosmesis is an undisputed benefit of
ini-VS. In a study of patients having a right thoracotomy,
asselman et al. (52) reported that approximately 99% of
atients thought that their scar was esthetically pleasing.
eurological events. Due to the physical limitations of
ini-VS, inadequate de-airing leading theoretically to a
igher incidence of neurological complications was a pri-
ary concern, making the use transesophageal echocardi-
graphy mandatory, which had minimized air emboli and
troke in the BWH series. In their early series, Mohr et al.
34) reported an 18% incidence of post-operative confusion;
owever, continuous CO2 insufflation was not used, as in
ore recent series. One decade later, Seeburger et al. (50)
Mohr’s Leipzig group) observed post-operative neurologi-
al impairment in 41 of 1,339 patients (3.1%) who under-
ent mini-MVS, with 28 (2.1%) minor and 13 (1.0%)
ajor events. Ten different studies reported no difference in
he incidence of stroke (27,42–44,46,47), whereas 2 found
decreased incidence with a minimally-invasive approach
17,46). In a systemic meta-analysis (53), there was no
ignificant difference in neurological events in 6 eligible
tudies including a total of 1,801 patients.
leeding transfusion and re-exploration. Smaller inci-
ions should theoretically reduce post-operative bleeding
nd transfusion requirements, notably with the significant
orbidity/mortality associated with transfusions and bleed-
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Minimally-Invasive Cardiac Valve Surgery August 3, 2010:455–62ng re-exploration (54). Some studies report no difference in
ransfusion requirements (55), whereas others note fewer
lood product transfusions with mini-VS. However, in
ost case, these data are not risk adjusted (56,57). In a
rospective, randomized trial, Dogan et al. (58) found a
ignificant decrease in post-operative chest tube output in
he mini-VS group compared with the conventional group.
thers, for example, Grossi et al. (48) (case-control study),
ound that a right thoracotomy was associated with 51%
ewer blood products than a conventional sternotomy. In
obotically assisted MVR, transfusion requirements are even
ower (20% to 45% require transfusions) (18,59).
Furthermore, 4 comparative studies found less blood loss:
mini-thoracotomy was used in 3 (17,27,32) and a paraster-
al approach was used in 1 (49). Chitwood et al. (17)
emonstrated no difference in blood loss/blood product
ransfusions in 31 video-assisted MV procedures, compared
ith conventional sternotomy, despite fewer re-explorations
or bleeding. The addition of a voice-activated robotic
amera led to a decrease in blood loss as well as in CPB and
ross-clamp times (27). Three of 10 studies found reduced
ransfusion requirements with a minimally-invasive approach
ompared with conventional surgery (14,47,48), whereas
he others showed no difference (17,27,32,43,49,54,60). In
atients 70 years or older, Grossi et al. (47) found reduced
lasma transfusions with a minimally-invasive (n  111)
ompared with a conventional (n  259) approach. More
onvincing evidence came from a subsequent study by the
ame group that showed 13% fewer total transfusions with
.8 fewer units of red blood cells using a mini-thoracotomy
ompared with a conventional sternotomy (48). Similar data
ere confirmed by Cohn et al. (14) in patients undergoing
ini-MVS. Two of 7 studies (17,27) demonstrated a
educed need for reoperation for bleeding with a minimally-
nvasive approach (3,42–44,49). Further, 5 studies showed
significant reduction in reoperations for bleeding with
minimally-invasive approach (n  1,553, p  0.02)
3,42–44,49). The recent data of the Leipzig group on
ost-operative course included reoperation for bleeding in
9 patients (5.1%) (50).
In another study regarding AV surgery, Soltesz and Cohn
2) found that in 890 minimally-invasive AV surgeries,
ost-operative bleeding necessitating reoperation occurred
n 2.6% (23 of 890); 50% of patients required blood
ransfusion (mean transfusion 1.8 U/patient).
F. Theoretically, it has been suggested that a less trau-
atic surgical approach would trigger less post-operative
F. However, 5 of 6 studies demonstrated that this is
ot the case (17,27,32,42,43,61). A meta-analysis of 4
ligible studies revealed no significant difference between
inimally-invasive and sternotomy approaches (n  539,
 0.45). Asher et al. (61) addressed this question in a
ohort of 100 patients having elective primary minimally-
nvasive AV or MV surgery compared with a matched
ontrol group undergoing conventional sternotomy. They
ound a similar prevalence of post-operative AF using either pethod, even after stratifying for valve type. However, the
AIR registry reported a 10% incidence of new-onset AF
ith the port access technique, which is lower than that
xpected for sternotomy (32).
ound infection. The incidence of wound infections and
eptic complications is lower with a thoracotomy than with
median sternotomy. This virtually eliminates mediastinitis
47,48), which is uncommon but possible after a partial
ternotomy. Grossi et al. (48) reported an incidence of 0.9%
or mini-thoracotomy and 5.7% for sternotomy cases (p 
.05). This had increased to 1.8% and 7.7%, respectively, in
lderly patients (p  0.03) (48), whereas Felger et al. (27)
eported no significant differences.
It is important to note that there is an additional risk of
roin complications associated with mini-VS. Such compli-
ations are now added complications, not present with a
raditional sternotomy approach.
ain, quality of life, and recovery. Compared with a
omplete sternotomy, thoracotomy incisions are associated
ith less pain, discomfort, and post-operative analgesics
27). Port access in completely endoscopic robotic ap-
roaches may further reduce post-operative discomfort.
lso, lower narcotic requirements may potentially reduce
ost-operative delirium (27). Within 4 weeks after a right
horacotomy, approximately one-half of the patients return
o work and full activity (17).
Post-operative pain and quality of life were evaluated
rom 1996 to 1997 by the Leipzig group using different
coring systems (62). This group revealed less pain from the
hird post-operative day onward after a lateral mini-
horacotomy (vs. a standard sternotomy) (62). Better stabil-
ty of the bony thorax leads to earlier mobilization and
eturn to daily activities. Thus, patient-related factors are a
ignificant advantage of mini-VS. In concordance with their
ndings, Yamada et al. (60) in 2003 compared early
ost-operative quality of life in mini-VS and conventional
alve surgery.
Of all the potential benefits of mini-VS (e.g., improved
osmesis, less pain), faster return to normal activity is the
ost consistent finding. Four studies measuring post-
perative pain exist, and all found a reduction of pain
ompared with a sternotomy (14,32,54,55); 2 studies re-
orted a faster return to normal activities (14,32). Glower et
l. (32) found that post-operative pain resolved more
uickly with a minimally-invasive approach; patients re-
urned to normal activity 5 weeks earlier than after a median
ternotomy (4  2 weeks vs. 9  1 week, p  0.01). At
WH (14), we found less pain (in-hospital and after
ischarge), less analgesic use, greater patient satisfaction,
nd return to normal activity 4.8 weeks before sternotomy
atients. Mihaljevic et al. (3) noted patients undergoing
inimally-invasive aortic surgery had shorter length of stay
nd with more frequent discharge home without additional
tationary rehabilitation services. Casselman et al. (52)
eported that 94% of their patients reported no or mild
ost-operative pain, 99.3% reported an esthetically pleasing
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August 3, 2010:455–62 Minimally-Invasive Cardiac Valve Surgerycar, 93% would choose the same procedure again if they
eeded additional surgery, and 46% returned to work within
weeks. Perhaps the most insightful evidence comes from
studies reporting that patients undergoing surgery via a
inimally-invasive approach as their second procedure all
hought that their recovery was faster/less painful than their
riginal sternotomy (27,63).
The use of small incisions, which necessitates, for exam-
le, rib retractors, results in less pain, given less stretching of
he muscle fibers, compared with sternotomy retractors.
ospital stay and costs. Minimally-invasive approaches
ppear to be associated with faster recovery, earlier dis-
harge, and reduced use of rehabilitation facilities
13,55,58,64,65). Does a rapid recovery translate into a
horter hospital stay/reduced costs? Although cost data for
ini-VS have not been thoroughly evaluated, length of
ospital stay is a known surrogate for resource use and
ospital costs (54). Asher et al. (61) found that patients who
nderwent an upper hemisternotomy had significantly less
erceived pain, shorter hospital stay, and a greater propor-
ion of home discharges than those who had conventional
ull sternotomies.
Eight of 14 studies reported a shorter hospital stay with
minimally-invasive approach (3,14,17,27,32,43,46–49,62).
nly 5 studies were eligible for the meta-analysis of Modi
t al. (53), and although the trend indicated this to be the
ase, the result was not statistically significant (350 patients,
 0.07). Chitwood et al. (17), Cohn et al. (14), and Navia
nd Cosgrove (13) equated this trend to a 34%, 20%, and
% cost saving, respectively. Moreover, these patients had
ewer requirements for rehabilitation, a significant advan-
age in health care savings: 91% were discharged home
ompared with 67% with conventional approach (3,14).
ntermediate and long-term results. Mihaljevic et al. (3),
rom Boston, presented mini-MVS with actuarial survival
ates of 98%, 97%, and 95% at 1, 3, and 5 years, respectively.
mong patients undergoing conventional sternotomy, there
ere actuarial survival rates of 97%, 91%, and 86% at 1, 3,
nd 5 years, respectively (p  0.03). Regarding mini-AVS,
hey also reported 24 of 526 (5%) late deaths in the
ollow-up of the minimally-invasive group for actuarial
urvival rates of 98%, 94%, and 82% at 1, 3, and 5 years,
espectively, compared with 56 of 516 deaths (10.8%) in the
onventional sternotomy group for the actuarial survival
ates of 94%, 90%, and 86% at 1, 3, and 5 years, respectively
p  0.006) (3).
The data presented by Seeburger et al. (50) showed the
ollowing results. The Kaplan-Meier estimate for survival at
years was 82.6%, and freedom from MV-related reopera-
ion was 96.3%.
Comparing a consecutive cohort of 100 mini-thoracotomy
VSs with the previous 100 sternotomy MVSs, Grossi et
l. (44) found a comparable 1-year freedom from reopera-
ion rate (96.8% vs. 94.4%, p  0.38) with similar net
mprovement in functional class. Mihaljevic et al. (3) re-
orted a significantly better actuarial survival rate at 5 years dor mini-MVS compared with sternotomy patients (95% vs.
6%), but this may be explained by a lower risk profile.
any of the cohort studies are temporally updated results
rom a few high-volume centers (Cleveland Clinic, BWH,
ew York University Medical Center, Leipzig). Therefore,
nly the most recent data from 10 cohorts with 6,479 patients
re considered (2,32,51,52,66–70). The crude unadjusted
ortality rates for the entire cohort are 1.1% for MVR and
.9% for MV replacement. The corresponding data from the
TS 2007 report (71) are 1.5% for MVP and 5.5% for MVR.
ith regard to long-term survival, there are 7 studies
eporting survival rates from 100% at a mean of 2.3 years to
3% at 6.8 years post-operatively (29,33,52,66,68–70). This
ompares favorably with the 5-year survival rates of 86.4%
eported by the Mayo Clinic (72) and 82% reported by the
leveland Clinic (73). Five studies reported freedom-from-
eoperation rates ranging from 99.3% at 3.2 years to 91% at
years (29,52,68–70). The longest follow-up was 6.3 years,
ith a 96.2% freedom-from-reoperation rate. Again, this
ompares favorably with the Mayo Clinic data, which
ndicate a risk of reoperation of between 0.5%/year for
solated posterior leaflet prolapse and 1.64%/year for iso-
ated anterior leaflet prolapse (57).
lderly patients. Two studies looked at minimally-invasive
echniques in elderly patients (47,74). Grossi et al. (47)
eviewed 111 patients undergoing mini-VS who were at
east 70 years old and compared them with 259 patients
ndergoing a sternotomy. The minimally-invasive group
ad a significantly lower incidence of sepsis and wound
omplications, required fewer frozen plasma transfusions,
nd had a shorter hospital stay. The authors concluded that
his approach can be used safely in operations on the elderly
opulation with excellent results. Also, Tabata and Cohn
74) recently reported 123 cases of mini-MVR in patients
ged 70 years and older with a 1.6% operative mortality rate
s well as a 5-year actuarial survival rate of 87% and a 5-year
reedom from reoperation rate of 93%.
As mentioned previously, at BWH, Soltesz and Cohn (2)
oted that 157 minimally-invasive AV replacements were
erformed on patients 80 years of age or older with an
perative mortality rate of 1.9% (3 of 157) with no mortality
n the 34 octogenarians. This suggests that the benefits of
ini-VS may be increased in higher-risk subgroups.
ini-VS criteria. Despite the highly encouraging results
rom mini-VS, the criteria are both surgeon and patient
ependent and on a case-by-case basis. With different
raining backgrounds, patient populations, and surgical
pproaches, surgeons should use the technique that they
elieve will result in the best outcome and with which they
eel more comfortable. However, at the BWH, we perform
ini-VS in patients with obesity and chest wall deformity
nd those at higher risk of sternal infections. Contraindi-
ations for mini-VS include concomitant cardiac procedures
i.e., valve  coronary artery bypass graft, multiple-valve
isease).
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ardiac valve surgery operations have historically been
erformed via a standard median sternotomy and CPB.
ith the advent of minimally-invasive surgery, several new
bservations regarding the treatment of patients with iso-
ated valve disease have arisen. Patients now demand less
nvasive procedures with equivalent safety, efficacy, and
urability. New surgical techniques should lead to smaller
ncisions, less blood loss, shorter hospital stays, and lower
ost (74–84). Given the unprecedented increasing costs of
ealth care, mini-VS provides a solution for savings. We are
hus convinced that the future of cardiac surgery is mini-VS.
New technology and techniques must provide the same
afety and quality as conventional methods. If scientific
vidence shows mini-VS results in lower complication rates,
urgeons must be trained in the newer techniques. However,
ith different training backgrounds, patient populations,
nd surgical approaches, surgeons should use the technique
hat they believe will result in the best outcome and with
hich they feel most comfortable.
In this review, we provide an overview of the exciting
esults of mini-VS. Several obstacles in the literature on
ini-VS exist, which makes a clear definition of
minimally-invasive” difficult. The STS (71) defines
inimally-invasive surgery as any procedure not performed
ith a full sternotomy and CPB; this definition is problem-
tic in valve surgery.
Second, a true randomized, prospective trial comparing
ini-VS and conventional VS does not exist. We must
herefore rely on prospective, high-volume, and single-
enter clinical evaluation trials. After comparing the out-
omes of the high-volume centers (BWH, East Carolina
niversity, Cleveland Clinic, Leipzig, Aalst, New York
niversity Medical Center, and others), there are promising
ata regarding mortality rates. The studies that we reviewed
o not show a significant difference in overall mortality
etween minimally-invasive and conventional approaches.
nterestingly, the different types of minimally-invasive ap-
roaches (right thoracotomy vs. partial sternotomy with
, C, T, or L type, with the exception of the port access
ethod) do not play an important role (77,85–91). It is clear
hat the mortality rate is unchanged and independent of the
pproach used. We have also reviewed secondary factors:
urgical trauma, post-operative complications, intensive care
nit/hospital stay, pain, quality of life, and costs.
With mini-VS, scepticism still exists (i.e., potential
tradeoff” of smaller incisions and limited exposure). As
ith any new procedure, a learning curve exists that influ-
nces outcomes. Nevertheless, high-volume centers have
roven that mini-VS can be performed as safely and
xpeditiously as conventional surgery.
One disadvantage has been the use of femoral cannula-
ion and perfusion. In fact, groin complications (e.g.,
nfections, arterial dissections/hematoma) account for mor-
0idity unseen with conventional sternotomy. In addition,
etrograde aortic dissections may occur; thus, the thoracic
orta is monitored for severe atherosclerotic changes by
reoperative transesophageal echocardiography before using
he technique. The question is: can surgeons provide the
ame quality without complete exposure of the heart? The
nswer, based on our vast experience, is an emphatic “yes!”
he quality of valve surgery has been equal to that of the
tandard operations. We have not experienced perivalvular
eaks in any of the valves implanted, and there has been
xcellent visualization to perform complicated MVR, in-
luding leaflet resection, chordoplasty, and commissuro-
lasty, documented by intraoperative and post-operative
ransesophageal echocardiography. Thus, we believe that
he quality of operations has not been mitigated.
In several studies, the ischemia time and bypass times are
omewhat longer than with the standard operation, but the
ength of stay and total costs were less than for standard
rocedures. Conversely, we learned that in high-risk pa-
ients, minimally-invasive procedures may not be as useful
iven the necessity for speed and efficiency to minimize
schemia and bypass times. Indeed, some of the outliers in
he reviewed series were sicker patients who might benefit
rom limited incisional trauma, but may have lingered
onger in the hospital because of slightly increased perfusion
nd ischemia times.
Finally, these techniques are a paradigm for the future in
erms of cost-effectiveness. If the same quality of operation
an be performed through a less traumatic/better cosmetic
ncision, resulting in a shorter hospital stay and lower overall
ost, this approach would coincide with the goals of man-
ged care. It is estimated that post-hospital care exceeds
illions of dollars in the U.S.; thus, patients would have less
eed for rehabilitation.
Data for mini-VS after previous cardiac surgery are
imited but consistently demonstrate reduced blood loss,
ewer transfusions, and faster recovery compared with repeat
ternotomy. Almost every patient who has undergone
ini-VS after a previous sternotomy reports a less painful
ecovery. As for the future, mini-VS is likely to become
idely adopted as patients will not opt for a sternotomy.
owever, despite the enthusiasm for minimally-invasive
rocedures, caution cannot be overemphasized because tra-
itional cardiac operations have proven long-term success
nd remain our measure for comparison. Surgeons perform-
ng mini-VS should be very experienced in the standard
pproach and diligent in evaluating the results to ensure the
ighest quality of valve surgery.
eprint requests and correspondence: Dr. Lawrence H. Cohn,
ivision of Cardiac Surgery, Brigham and Women’s Hospital,
arvard Medical School, 75 Francis Street, Boston, Massachusetts
2115. E-mail: lhcohn@partners.org.
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